Introduction Alzheimer’s disease is a serious medical condition that affects millions of people worldwide. It…
News & Events
Stay updated on our latest news and activities
OptoCeutics is Presenting at The 15th Clinical Trial on Alzheimer’s Disease (CTAD 2022)
Copenhagen, Denmark, 24 November 2022 – OptoCeutics ApS (”OptoCeutics” or ”The Company”) is pleased to…
OptoCeutics Launches ALZLIGHT Stage III Clinical Trial
Study on the Effect of 40 Hz Non-Invasive Light Therapy System The ALZLIGHT STAGE III…
Natural Brainwaves: A Novel Therapeutic Target to Restore Brain Health
❚ Brain Waves Brain waves are electrical impulses in the brain. They are at the…
What Happens When Your Brain Network Fails?
❚ Brain Networks The brain is an astonishing and complex organ that shapes the way…
We have delivered 26 devices to Zealand University Hospital
OptoCeutics is pleased to announce the delivery of 26 devices to Zealand University Hospital for…
We have started our clinical study for Alzheimer’s
Study on Safety, Feasibility and Neural Activation of Non-Invasive Light Therapy System Recent studies in…
We are happy to announce our participation in the EU-funded Astrotech Project
This grant will enable OptoCeutics to hire two PhD candidates to conduct research in collaboration…
TV2 Lorry
TV2 Lorry has followed us for a long time in connection with our participation in…
Danish Tech Challenge Award Show
TV2 Lorry has followed us for a long time in connection with our participation in the Danish Tech Challenge.
